FDA OKs Oxoid's rapid antimicrobial susceptibility test:
This article was originally published in Clinica
Executive Summary
Oxoid has received US FDA 510(k) clearance to market its antimicrobial susceptibility test for detecting oxacillin/methicillin resistance. The PBP2' test, which identifies MRSA and MRCoNS, is the first rapid latex test to gain the nod in the US for confirming both Staphylococcus aureus and coagulase negative staphylococci, claims the Basingstoke, UK firm. Moreover, the company adds, the PBP2' test has demonstrated an accuracy of 100% compared with PCR.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.